School of Allied Health Sciences, Southeast Asia Water Team (SEA Water Team), World Union for Herbal Drug Discovery (WUHeDD), and Research Excellence Center for Innovation and Health Products (RECIHP), Walailak University, Nakhon Si Thammarat, Thailand.
Akkhraratchakumari Veterinary College and Research Center of Excellence in Innovation of Essential Oil, Walailak University, Nakhon Si Thammarat, Thailand.
Sci Rep. 2021 Apr 13;11(1):8053. doi: 10.1038/s41598-021-87381-x.
Acanthamoeba spp. can cause amoebic keratitis (AK). Chlorhexidine is effective for AK treatment as monotherapy, but with a relative failure on drug bioavailability in the deep corneal stroma. The combination of chlorhexidine and propamidine isethionate is recommended in the current AK treatment. However, the effectiveness of treatment depends on the parasite and virulence strains. This study aims to determine the potential of Garcinia mangostana pericarp extract and α-mangostin against Acanthamoeba triangularis, as well as the combination with chlorhexidine in the treatment of Acanthamoeba infection. The minimal inhibitory concentrations (MICs) of the extract and α-mangostin were assessed in trophozoites with 0.25 and 0.5 mg/mL, for cysts with 4 and 1 mg/mL, respectively. The MIC of the extract and α-mangostin inhibited the growth of A. triangularis trophozoites and cysts for up to 72 h. The extract and α-mangostin combined with chlorhexidine demonstrated good synergism, resulting in a reduction of 1/4-1/16 of the MIC. The SEM results showed that Acanthamoeba cells treated with a single drug and its combination caused damage to the cell membrane and irregular cell shapes. A good combination displayed by the extract or α-mangostin and chlorhexidine, described for the first time. Therefore, this approach is promising as an alternative method for the management of Acanthamoeba infection in the future.
棘阿米巴属可引起阿米巴角膜炎(AK)。洗必泰单独使用可有效治疗 AK,但深层角膜基质中的药物生物利用度相对较低。目前推荐使用洗必泰和丙脒腙联合治疗 AK。然而,治疗效果取决于寄生虫和毒力株。本研究旨在确定藤黄果皮提取物和 α-倒捻子素对三角棘阿米巴的潜在作用,以及与洗必泰联合治疗棘阿米巴感染的作用。用 0.25 和 0.5 mg/mL 的提取物和 α-倒捻子素评估滋养体的最小抑菌浓度(MIC),用 4 和 1 mg/mL 的提取物和 α-倒捻子素评估包囊的 MIC。提取物和 α-倒捻子素的 MIC 可抑制三角棘阿米巴滋养体和包囊的生长,最长可达 72 小时。提取物和 α-倒捻子素与洗必泰联合使用表现出良好的协同作用,使 MIC 降低了 1/4-1/16。SEM 结果显示,用单一药物及其组合处理的棘阿米巴细胞导致细胞膜损伤和细胞形状不规则。这是首次描述提取物或 α-倒捻子素与洗必泰的良好组合。因此,这种方法有望成为未来棘阿米巴感染管理的替代方法。